RTP Mobile Logo

First-in-Human Study of the Oral ALK Inhibitor Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

5-Minute Journal Club — ASCO 2010 Presentations

5-Minute Journal Club — ASCO 2010 Presentations

 

Safety and Efficacy of Bosutinib in Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After Resistance or Intolerance to Imatinib

Update of the ENESTnd Study: Comparison of Nilotinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP)

5-Minute Journal Club — ASCO 2010 Presentations

5-Minute Journal Club — ASCO 2010 Presentations

 

Atlas of Molecular Oncology - Critical Pathways in Breast Cancer Treatment

Eribulin versus Treatment of Physician’s Choice for Patients with Heavily Pretreated Advanced Breast Cancer

Activity of Bevacizumab in Combination with First- and Second-Line Chemotherapy for Metastatic Breast Cancer (mBC)

Combination Anti-HER2 Therapy with Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer (mBC) Previously Treated with Trastuzumab

Effect of Targeted Intraoperative Radiation Therapy on Local Recurrence Rate in Early Breast Cancer

Clinical Trials Evaluating the Role of Sentinel Node Resection (SNR) in Early-Stage Breast Cancer

5-Minute Journal Club — ASCO 2010 Presentations

5-Minute Journal Club — ASCO 2010 Presentations

 

Effects of Zoledronic Acid on Overall Survival in Newly Diagnosed Multiple Myeloma (MM)

Lenalidomide Maintenance After Autologous Transplantation for Myeloma